NIHR and Sanofi Announce First Patient Enrolled in Large European Clinical Study to Investigate Protection Against RSV, the Leading Cause of Infant Hospitalisation Worldwide - Yahoo Finance
8/12/2022 12:00:00 AM2 years 9 months ago
by Business Wire
by Business Wire
READING, England, August 12, 2022--First patient enrolled in large European clinical study to investigate protection against RSV, the leading cause of infant...
READING, England, August 12, 2022--(BUSINESS WIRE)--Sanofi (EURONEXT: SAN and NASDAQ: SNY) and the National Institute for Health and Care Research (NIHR) have today announced that the first patient h… [+11321 chars]
full article...